Monthly Archives: October 2021

Aditpotide, also known as FTPP, is an experimental weight loss peptidomimetic with the amino acid sequence CKGGRAKDC-GG-D(KLAKLAK)2, which has been developed by researchers in the United States in an effort to fight obesity. Peptidomimetics are small protein-like chains designed to mimic a peptide. The peptide called Adipotide has been developed by U.S. researchers in the fight against obesity. This experimental treatment has reduced by 11% the weight of the treated monkeys by reducing fatty tissue, the BMI, and waist circumference.

Aditpotide side effects

Aditopotide has the ability to diminish blood vessels in soft tissue that feed fat cells under laboratory conditions with few if any side effects such as redness or itching at site of injection and some minor dehydration which should be accounted for during trial. There are no known health risks associated with DSIP injections, especially when compared to traditional hormone-based

Follistatin also known as activin-binding protein is a protein that in humans is encoded by the FST gene. Follistatin is an autocrine glycoprotein that is expressed in nearly all tissues of higher animals. Its primary function is the binding and bio neutralization of members of the TGF-β superfamily, with a particular focus on activin, a paracrine hormone.

In short, follistatin has been reported to boost metabolism, grow muscle, and increase fertility in laboratory animal trials.

Follistatin side effects

Follistatin has the ability to promote muscle growth and strength under laboratory conditions with few if any side effects such as redness or itching at site of injection and some minor muscle swelling and soreness. There are no known health risks associated with DSIP injections, especially when compared to traditional hormone-based metabolic, strengthening and fertility treatments when compared side by side in animal studies.

DSIP otherwise known as delta sleep-inducing peptide is a naturally occurring neuropeptide, it was originally isolated from a rabbit brain in 1977. DSIP promotes a specific type of sleep, non-REM sleep also known as slow wave sleep. DSIP promotes healthy sleep regulation.

DSIP side effects

DSIP has the ability to promote or induce sleep in animals under laboratory conditions with few if any side effects such as redness or itching at site of injection and some minor dizziness. There are no known health risks associated with DSIP injections, especially when compared to traditional hormone-based sleep treatments when compared side by side in animal studies.

DSIP dosage

During trials, 0.1mL of DSIP injected subcutaneously once daily, one to two hours before sleeping garnered optimum results. Dose should be administered at least three hours after eating.

The products

CJC-1295 DAC has shown some amazing results as a growth hormone releasing hormone (GHRH) analog. Not only has CJC-1295 shown the ability to increase growth hormone and IGF-I secretion and its benefits, but it has been able to do so in very large amounts. Recent research studies have shown that CJC – 1295 stimulates GH and IGF-1 Secretion and will keep a steady increase of HGH and IGF-1 with no increase in prolactin, leading to intense fat loss, and increases protein synthesis.

CJC-1295 DAC side effects

CJC-1295 DAC has reported minimal to no side effects in lab trials, some effects may include redness or itching at site of injection and some minor dizziness. There are no known health risks associated with CJC-1295 DAC injections, especially when compared to traditional hormone-based weight loss treatments when compared side by side in animal studies.

CJC-1295 DAC dosage

Majority